Premier Alternatives

Phagos

Suresnes, France · Founded 2021 · Privately Held (backing)

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. Phagos is based in Suresnes, France and was founded in 2021. It was valued at $59.9 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $31.9 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2022.

PMV mark · valuation
$59.9M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$31.9M
Last round
Seed Round
Jul 2022

Phagos key facts

as of Oct 2026
  • Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming.
  • Phagos is valued at approximately $59.9M as of Oct 2026, set at its early-stage round, Oct 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $31.9M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Jul 2022.
  • Notable investors include Bpifrance, Entrepreneurs First, AWS Startups, Agoranov, StartLife — 26 tracked in total.
  • Phagos has filed 2 Form Ds with the SEC since 2022, most recently Nov 2024 ( sold to 13 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$59.9M

Valued at $59.9M at its early-stage round, Oct 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Phagos with a free account
  • ·The complete investor list: 26 names
  • ·Watch Phagos: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Phagos funding rounds

1 rounds
Jul 2022Seed Round$1.5MSEC filing▮
Full funding history →

Phagos valuation

Phagos was valued at $59.9 million at its early-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Phagos raised?

Phagos has raised $31.9 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Jul 2022.

Phagos has filed 2 Form Ds with the SEC since 2022, most recently in Nov 2024 (null sold to 13 investors).

Phagos investors

26 investors are on record for Phagos, including Bpifrance, Entrepreneurs First, AWS Startups and Agoranov. The seed round in Jul 2022 drew 7 investors.

About Phagos

Operator of a biotechnology research company intended to provide customizable drugs to replace antibiotics in animal farming. The company uses a natural predator of bacteria that can constitute an efficient and sustainable alternative to antibiotics, enabling health professionals to overcome incurable and deadly infectious diseases.

Sector
Healthcare
HQ
Suresnes, France
Founded
2021
Employees
50
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.